- Home
- SPRB vs EQS Comparison
SPRB vs EQS Comparison
Compare SPRB & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRB
- EQS
- Stock Information
- Founded
- SPRB 2014
- EQS 1991
- Country
- SPRB United States
- EQS United States
- Employees
- SPRB N/A
- EQS N/A
- Industry
- SPRB Medicinal Chemicals and Botanical Products
- EQS Finance Companies
- Sector
- SPRB Health Care
- EQS Finance
- Exchange
- SPRB Nasdaq
- EQS Nasdaq
- Market Cap
- SPRB 22.8M
- EQS 18.5M
- IPO Year
- SPRB 2020
- EQS N/A
- Fundamental
- Price
- SPRB $0.52
- EQS $1.38
- Analyst Decision
- SPRB Hold
- EQS
- Analyst Count
- SPRB 7
- EQS 0
- Target Price
- SPRB $2.50
- EQS N/A
- AVG Volume (30 Days)
- SPRB 400.8K
- EQS 2.7K
- Earning Date
- SPRB 11-11-2024
- EQS 01-01-0001
- Dividend Yield
- SPRB N/A
- EQS N/A
- EPS Growth
- SPRB N/A
- EQS 231.84
- EPS
- SPRB N/A
- EQS 0.71
- Revenue
- SPRB $7,101,000.00
- EQS $845,000.00
- Revenue This Year
- SPRB N/A
- EQS N/A
- Revenue Next Year
- SPRB N/A
- EQS N/A
- P/E Ratio
- SPRB N/A
- EQS $1.83
- Revenue Growth
- SPRB N/A
- EQS 4594.44
- 52 Week Low
- SPRB $0.41
- EQS $1.19
- 52 Week High
- SPRB $5.95
- EQS $1.95
- Technical
- Relative Strength Index (RSI)
- SPRB 47.26
- EQS 46.91
- Support Level
- SPRB $0.51
- EQS $1.26
- Resistance Level
- SPRB $0.56
- EQS $1.35
- Average True Range (ATR)
- SPRB 0.03
- EQS 0.04
- MACD
- SPRB -0.01
- EQS -0.00
- Stochastic Oscillator
- SPRB 16.61
- EQS 33.33
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.